The Opioid Taper Caper: Deciphering and Deflating Daily Dilemmas

The ever-expanding fear associated with prescribing opioids driven by policies, “guidelines,” and recommendations has swung the pendulum from opiophilia to opiophobia. Primary care providers have found themselves often in the crosshairs of a hotly contested debate: To taper or not to taper? Unfortunately, the answer has been leaning progressively toward the taper end of this spectrum. The struggle that many clinicians face regarding tapering is usually not with the execution of how to taper, but with the appropriate way to communicate the taper to the patient to ensure the optimal outcome. This multidisciplinary, interactive presentation is designed to discuss how to establish when a taper is necessary, the differences between appropriate forced and shared-decision tapering, and, perhaps most importantly, how to communicate effectively with the patient. It will also address strategies for handling conversations regarding inconsistent urine drug screen results and the proper response that healthcare professionals should have regarding these results and/or potential aberrant patient behaviors. The final third of this course will be open for questions, giving lecturers the opportunity to offer specific expertise.

Learning Objectives

  • Identify situations where tapering is appropriate versus inappropriate
  • Delineate between appropriate forced tapering versus shared-decision making tapering
  • Demonstrate proper communication techniques when discussing potential tapers with patients
  • Recognize effective approaches and responses to minimize psychological consequences when tapering

Additional Information

AttachmentSize
PDF icon Slides and Disclosures908.34 KB
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
06/01/2021
Course expires: 
06/01/2022
Rating: 
0

image

Jeffrey J. Bettinger, PharmD

Pain Management Clinical Pharmacist
Saratoga Hospital Medical Group
Schenectady, New York

 

image

Jeff Fudin, PharmD, DAIPM, FCCP, FASHP

President
Remitigate Therapeutics
Albany College of Pharmacy
Delmar, New York

image

Michael E. Schatman, PhD, CPE, DASPE

Adjunct Clinical Assistant Professor
Tufts University School of Medicine, Department of Public Health & Community Medicine
Jamaica Plain, Massachusetts

Available Credit

  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.